DEPO MEDRONE V, 40 mg/ml injekcinė suspensija šunims, katėms ir arkliams
DEPO MEDRONE V, 40 mg/ml injekcinė suspensija šunims, katėms ir arkliams
Authorised
- Methylprednisolone acetate
Product identification
Medicine name:
DEPO MEDRONE V, 40 mg/ml injekcinė suspensija šunims, katėms ir arkliams
Active substance:
- Methylprednisolone acetate
Target species:
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intrasynovial use
Product details
Active substance and strength:
-
Methylprednisolone acetate40.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Horse
-
Dog
-
Cat
-
-
Intrasynovial use
-
Horse
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Available in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Pfizer Manufacturing Belgium
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/02/1436/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1436.pdf
Lithuanian (PDF)
Download Published on: 8/04/2024
How useful was this page?: